IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $382,635,000 | +63.4% | 4,500,000 | -31.9% | 13.22% | +28.5% |
| Q2 2020 | $234,117,000 | +105.5% | 6,606,000 | -21.8% | 10.29% | +32.6% |
| Q1 2020 | $113,906,000 | -36.3% | 8,450,000 | 0.0% | 7.76% | -23.2% |
| Q4 2019 | $178,802,000 | +94.0% | 8,450,000 | +21.6% | 10.11% | +51.3% |
| Q3 2019 | $92,157,000 | +1.2% | 6,950,000 | +5.8% | 6.68% | -14.7% |
| Q2 2019 | $91,084,000 | +15.6% | 6,567,000 | +60.2% | 7.83% | -14.0% |
| Q1 2019 | $78,761,000 | +379.9% | 4,100,000 | +256.5% | 9.11% | +349.1% |
| Q4 2018 | $16,411,000 | – | 1,150,000 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|